期刊文献+

冠状动脉支架内再狭窄的研究新进展 被引量:21

下载PDF
导出
摘要 近年来,经皮冠状动脉介入治疗(PCI)已经发展成为冠心病的最有效的治疗方法之一。但PCI尚存在支架内再狭窄(ISR)的难题。药物洗脱支架(DES)可以减少ISR的发生,但不能完全解决。据统计,每年在美国DES发生ISR的患者仍有近20万。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2016年第5期1264-1267,共4页 Chinese Journal of Gerontology
  • 相关文献

参考文献27

  • 1Hao PP,Chen YG,Wang XI,et al.Efficacy and safety of drug-eluting stems in patients with acute ST-segment-elevation myocardial infarction:a meta-analysis of randomized controlled trials〔J〕.Tex Hcart Inst,2010;37:516-24.
  • 2Byrne RA,Jonet M,Lastrati A.Stent thrombosis and restenosis:what have wei learned and where are we going?The Anddreas Grüntzig Lecture ESC 2014〔J〕.Eur Heart J,2015;36(47):3320-31.
  • 3Aminian A,Kabir T,Eeckhout E.Treatment of drug-eluting stent restenosis:an emerging challenge〔J〕.Catheter Cardiovasc Interv,2009;74(1):108-16.
  • 4Mehran R,Dangas G,Abizaid AS,et al.Angiographic patterns of in-stent restenosis:classification and implications for long-term outcome〔J〕.Circulation,1999;100(18):1872-8.
  • 5Jasti V,Ivan E,Yalamanchili V,et al.Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis〔J〕.Circulation,2004;110(18):2831-6.
  • 6Speidel CM,Eisenberg PR,Ruf W,et al.Tissue factor mediates prolonged proeoagulant activity on the luminal surface of balloon-injured aortas in rabbits〔J〕.Circulation,1995;92(11):3323-30.
  • 7Doi H,Maehara A,Mintz GS,et al.Impact of in-stent minimal lumen area at 9 months poststent implantation on 3-year target lesion revascularization-free survival:a serial intravascular ultrasound analysis from the TAXUSⅣ,Ⅴ,andⅥtrials〔J〕.Circ Cardiovasc Interv,2008;1(2):111-8.
  • 8张丽.冠状动脉支架内再狭窄的研究进展[J].山东医药,2013,53(33):98-99. 被引量:16
  • 9Komowski R,Hong MK,Tio FO,et al.In-stent restenosis:con-tribufions of inflammatory response and arterial injury to neointimal hyperplasia〔J〕.J Am Coil Cardiol,1998;31(1):224-30.
  • 10Glover C,Ma X,Chen YX,et al.Human in-stent restenosis tissue obtained by mean of coronary atherectomy consists of m abundant pmtesglycan matrix with a paucity of cell proliferation〔J〕.Am Heart J,2002;144(4):702-9.

二级参考文献70

  • 1田美蓉,李莉,赵碧琼,耿学斌,刘小坤,闫华.切割球囊在小血管病变介入治疗中的应用[J].山东医药,2007,47(4):32-32. 被引量:2
  • 2Elezi S,Kastrati A,Neumann FJ,et al.Vessel size and long-term outcome after coronary stent placement[J].Circulation,2008,98(18):1875-1880.
  • 3Mehran R,Dangas G,Abizaid AS,et al.Angiographic patterns of in-stent restenosis:classification and implications for long-term outcome[J].Circulation,1999,100(18):1872-1878.
  • 4Edelman ER,Rogers C.Pathobiologic response to stenting[J].Am J Cardiol,2008,81(7A):4E-6E.
  • 5Weintraub WS.The pathophysiology and burden of restenosis[J].Am J Cardiol,2007,100:53-59.
  • 6Brasen JH,Kivela A,Roser K,et al.Angiogenesis,vascular endothelial growth factor and platelet-derived growth factor-BB expression.iron deposition,and oxidation-specific epitopes in stented human coronary arteries[J].Aterioscler Thromb Vasc Biol,2001,21(11):1720-1726.
  • 7Topol EJ.Intensive Statin Therapy-A sea change in cardiovascular prevention[J].N Engl J Med,2004,350(15):1562-1564.
  • 8Brasen JH,Kivela A,Roser K,et al.Angiogenesis vascular endothelial growth factor and platelet-derived growth factor BB expression,iron deposition,and oxidation-specific epitopes in stented human coronary arteries[J].Arterioscler Thromb Vasc Biol,2001,21(11):1720-1726.
  • 9Rosenson RS,Tangney CC,Casey LC.Inhibition of proinflammatory cytokine production by pravastatin[J].Lancet,2005,353(9157):983-984.
  • 10Link A,Ayadhi T,Nickenig G,et al.Rapid immunomodulation by rosuvatatin in patients with acute coronary syndrome[J].Eur Heart J,2006,27(24):2945-2955.

共引文献54

同被引文献142

引证文献21

二级引证文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部